ID   CBPA6_HUMAN             Reviewed;         437 AA.
AC   Q8N4T0; Q8NEX8; Q8TDE8; Q9NRI9;
DT   07-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2006, sequence version 2.
DT   10-MAY-2017, entry version 142.
DE   RecName: Full=Carboxypeptidase A6;
DE            EC=3.4.17.-;
DE   Flags: Precursor;
GN   Name=CPA6; Synonyms=CPAH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RX   PubMed=11836249; DOI=10.1074/jbc.M112254200;
RA   Wei S., Segura S., Vendrell J., Aviles F.X., Lanoue E., Day R.,
RA   Feng Y., Fricker L.D.;
RT   "Identification and characterization of three members of the human
RT   metallocarboxypeptidase gene family.";
RL   J. Biol. Chem. 277:14954-14964(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND CHROMOSOMAL TRANSLOCATION.
RC   TISSUE=Retina;
RX   PubMed=12454025;
RA   Pizzuti A., Calabrese G., Bozzali M., Telvi L., Morizio E., Guida V.,
RA   Gatta V., Stuppia L., Ion A., Palka G., Dallapiccola B.;
RT   "A peptidase gene in chromosome 8q is disrupted by a balanced
RT   translocation in a duane syndrome patient.";
RL   Invest. Ophthalmol. Vis. Sci. 43:3609-3612(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   CYS-173.
RC   TISSUE=Hematopoietic stem cell;
RA   Gu J., Huang Q., Yu Y., Xu S., Han Z., Fu G., Chen Z.;
RT   "Novel genes expressed in hematopoietic stem/progenitor cells from
RT   myelodysplastic syndrome patients.";
RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   CYS-173.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, PROTEOLYTIC PROCESSING, AND SUBSTRATE
RP   SPECIFICITY.
RX   PubMed=18178555; DOI=10.1074/jbc.M707680200;
RA   Lyons P.J., Callaway M.B., Fricker L.D.;
RT   "Characterization of carboxypeptidase A6, an extracellular matrix
RT   peptidase.";
RL   J. Biol. Chem. 283:7054-7063(2008).
RN   [6]
RP   CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=20855895; DOI=10.1074/jbc.M110.158626;
RA   Lyons P.J., Fricker L.D.;
RT   "Substrate specificity of human carboxypeptidase A6.";
RL   J. Biol. Chem. 285:38234-38242(2010).
RN   [7]
RP   TISSUE SPECIFICITY, VARIANT ETL5 ARG-267, VARIANT FEB11 VAL-270,
RP   CHARACTERIZATION OF VARIANT ETL5 ARG-267, AND CHARACTERIZATION OF
RP   VARIANT FEB11 VAL-270.
RX   PubMed=21922598; DOI=10.1002/humu.21613;
RA   Salzmann A., Guipponi M., Lyons P.J., Fricker L.D., Sapio M.,
RA   Lambercy C., Buresi C., Bencheikh B.O., Lahjouji F., Ouazzani R.,
RA   Crespel A., Chaigne D., Malafosse A.;
RT   "Carboxypeptidase A6 gene (CPA6) mutations in a recessive familial
RT   form of febrile seizures and temporal lobe epilepsy and in sporadic
RT   temporal lobe epilepsy.";
RL   Hum. Mutat. 33:124-135(2012).
CC   -!- FUNCTION: May be involved in the proteolytic inactivation of
CC       enkephalins and neurotensin in some brain areas. May convert
CC       inactive angiotensin I into the biologically active angiotensin
CC       II. {ECO:0000269|PubMed:18178555}.
CC   -!- CATALYTIC ACTIVITY: Release of a C-terminal amino acid, with
CC       preference for large hydrophobic C-terminal amino acids and only
CC       very weak activity toward small amino acids and histidine.
CC       {ECO:0000269|PubMed:20855895}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:P00730};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250|UniProtKB:P00730};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=266 uM for 3-(2-furyl)acryloyl-Phe-Phe
CC         {ECO:0000269|PubMed:20855895};
CC         KM=100 uM for 3-(2-furyl)acryloyl-Phe-Tyr
CC         {ECO:0000269|PubMed:20855895};
CC         KM=386 uM for 3-(2-furyl)acryloyl-Phe-Leu
CC         {ECO:0000269|PubMed:20855895};
CC         KM=339 uM for 3-(2-furyl)acryloyl-Phe-Trp
CC         {ECO:0000269|PubMed:20855895};
CC         KM=786 uM for 3-(2-furyl)acryloyl-Phe-Met
CC         {ECO:0000269|PubMed:20855895};
CC       pH dependence:
CC         Optimum pH is 8. {ECO:0000269|PubMed:20855895};
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000269|PubMed:18178555}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8N4T0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8N4T0-2; Sequence=VSP_008808;
CC         Note=May be due to intron retention. No experimental
CC         confirmation available.;
CC       Name=3;
CC         IsoId=Q8N4T0-3; Sequence=VSP_058375, VSP_058376;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC   -!- TISSUE SPECIFICITY: Expressed in the hippocampus, nucleus raphe,
CC       and cortex. {ECO:0000269|PubMed:21922598}.
CC   -!- DISEASE: Note=A chromosomal aberration involving CPA6 was found in
CC       a patient with Duane retraction syndrome. Translocation
CC       t(6;8)(q26;q13).
CC   -!- DISEASE: Epilepsy, familial temporal lobe, 5 (ETL5) [MIM:614417]:
CC       A focal form of epilepsy characterized by recurrent seizures that
CC       arise from foci within the temporal lobe. Seizures are usually
CC       accompanied by sensory symptoms, most often auditory in nature.
CC       {ECO:0000269|PubMed:21922598}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Febrile seizures, familial, 11 (FEB11) [MIM:614418]:
CC       Seizures associated with febrile episodes in childhood without any
CC       evidence of intracranial infection or defined pathologic or
CC       traumatic cause. It is a common condition, affecting 2-5% of
CC       children aged 3 months to 5 years. The majority are simple febrile
CC       seizures (generally defined as generalized onset, single seizures
CC       with a duration of less than 30 minutes). Complex febrile seizures
CC       are characterized by focal onset, duration greater than 30
CC       minutes, and/or more than one seizure in a 24 hour period. The
CC       likelihood of developing epilepsy following simple febrile
CC       seizures is low. Complex febrile seizures are associated with a
CC       moderately increased incidence of epilepsy.
CC       {ECO:0000269|PubMed:21922598}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the peptidase M14 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAK84941.1; Type=Erroneous translation; Note=Wrong choice of CDS.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF466284; AAM19307.1; -; Genomic_DNA.
DR   EMBL; BK000188; DAA00037.1; -; mRNA.
DR   EMBL; AY044833; AAK84941.1; ALT_SEQ; mRNA.
DR   EMBL; AF221594; AAF91231.1; -; mRNA.
DR   EMBL; BC033684; AAH33684.1; -; mRNA.
DR   CCDS; CCDS6200.1; -. [Q8N4T0-1]
DR   RefSeq; NP_065094.3; NM_020361.4. [Q8N4T0-1]
DR   UniGene; Hs.658850; -.
DR   ProteinModelPortal; Q8N4T0; -.
DR   SMR; Q8N4T0; -.
DR   BioGrid; 121362; 11.
DR   STRING; 9606.ENSP00000297770; -.
DR   MEROPS; M14.018; -.
DR   iPTMnet; Q8N4T0; -.
DR   PhosphoSitePlus; Q8N4T0; -.
DR   BioMuta; CPA6; -.
DR   DMDM; 85683250; -.
DR   PaxDb; Q8N4T0; -.
DR   PeptideAtlas; Q8N4T0; -.
DR   PRIDE; Q8N4T0; -.
DR   Ensembl; ENST00000297770; ENSP00000297770; ENSG00000165078. [Q8N4T0-1]
DR   Ensembl; ENST00000479862; ENSP00000419016; ENSG00000165078. [Q8N4T0-3]
DR   Ensembl; ENST00000518549; ENSP00000431112; ENSG00000165078. [Q8N4T0-2]
DR   GeneID; 57094; -.
DR   KEGG; hsa:57094; -.
DR   UCSC; uc003xxq.5; human. [Q8N4T0-1]
DR   CTD; 57094; -.
DR   DisGeNET; 57094; -.
DR   GeneCards; CPA6; -.
DR   H-InvDB; HIX0007565; -.
DR   HGNC; HGNC:17245; CPA6.
DR   MalaCards; CPA6; -.
DR   MIM; 609562; gene.
DR   MIM; 614417; phenotype.
DR   MIM; 614418; phenotype.
DR   neXtProt; NX_Q8N4T0; -.
DR   OpenTargets; ENSG00000165078; -.
DR   Orphanet; 165805; Familial mesial temporal lobe epilepsy with febrile seizures.
DR   PharmGKB; PA38444; -.
DR   eggNOG; KOG2650; Eukaryota.
DR   eggNOG; COG2866; LUCA.
DR   GeneTree; ENSGT00760000119103; -.
DR   HOGENOM; HOG000252968; -.
DR   HOVERGEN; HBG050815; -.
DR   InParanoid; Q8N4T0; -.
DR   KO; K08782; -.
DR   OMA; RKHIRAY; -.
DR   OrthoDB; EOG091G0HUI; -.
DR   PhylomeDB; Q8N4T0; -.
DR   TreeFam; TF317197; -.
DR   GeneWiki; Carboxypeptidase_A6; -.
DR   GenomeRNAi; 57094; -.
DR   PRO; PR:Q8N4T0; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000165078; -.
DR   CleanEx; HS_CPA6; -.
DR   Genevisible; Q8N4T0; HS.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0005578; C:proteinaceous extracellular matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0004181; F:metallocarboxypeptidase activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   CDD; cd03872; M14_CPA6; 1.
DR   Gene3D; 3.30.70.340; -; 1.
DR   InterPro; IPR033843; CPAH.
DR   InterPro; IPR003146; M14A_act_pep.
DR   InterPro; IPR009020; Peptidase/Inhibitor_I9.
DR   InterPro; IPR000834; Peptidase_M14.
DR   Pfam; PF00246; Peptidase_M14; 1.
DR   Pfam; PF02244; Propep_M14; 1.
DR   PRINTS; PR00765; CRBOXYPTASEA.
DR   SMART; SM00631; Zn_pept; 1.
DR   SUPFAM; SSF54897; SSF54897; 1.
DR   PROSITE; PS00133; CARBOXYPEPT_ZN_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Carboxypeptidase; Chromosomal rearrangement;
KW   Cleavage on pair of basic residues; Complete proteome;
KW   Disease mutation; Disulfide bond; Epilepsy; Extracellular matrix;
KW   Glycoprotein; Hydrolase; Metal-binding; Metalloprotease; Polymorphism;
KW   Protease; Reference proteome; Secreted; Signal; Zinc; Zymogen.
FT   SIGNAL        1     30       {ECO:0000255}.
FT   PROPEP       31    129       Activation peptide. {ECO:0000250}.
FT                                /FTId=PRO_0000004365.
FT   CHAIN       130    437       Carboxypeptidase A6.
FT                                /FTId=PRO_0000004366.
FT   REGION      196    199       Substrate binding.
FT                                {ECO:0000250|UniProtKB:P00730}.
FT   REGION      271    272       Substrate binding.
FT                                {ECO:0000250|UniProtKB:P00730}.
FT   REGION      325    326       Substrate binding.
FT                                {ECO:0000250|UniProtKB:P00730}.
FT   ACT_SITE    398    398       Proton donor/acceptor.
FT                                {ECO:0000250|UniProtKB:P00732}.
FT   METAL       196    196       Zinc; catalytic.
FT                                {ECO:0000250|UniProtKB:P00730}.
FT   METAL       199    199       Zinc; catalytic.
FT                                {ECO:0000250|UniProtKB:P00730}.
FT   METAL       324    324       Zinc; catalytic.
FT                                {ECO:0000250|UniProtKB:P00730}.
FT   BINDING     254    254       Substrate.
FT                                {ECO:0000250|UniProtKB:P00730}.
FT   BINDING     376    376       Substrate.
FT                                {ECO:0000250|UniProtKB:P00730}.
FT   CARBOHYD     89     89       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    153    153       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    427    427       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    265    288       {ECO:0000250|UniProtKB:Q96IY4}.
FT   VAR_SEQ      65     92       VDLWQPSSISYVSEGTVTDVHIPQNGSR -> GPHRRSSEN
FT                                TGEGKQLAHPEKPKIPLWI (in isoform 3).
FT                                {ECO:0000303|PubMed:12454025}.
FT                                /FTId=VSP_058375.
FT   VAR_SEQ      93    437       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:12454025}.
FT                                /FTId=VSP_058376.
FT   VAR_SEQ     280    437       DEGASMHPCDDTYCGPFPESEPEVKAVANFLRKHRKHIRAY
FT                                LSFHAYAQMLLYPYSYKYATIPNFRCVESAAYKAVNALQSV
FT                                YGVRYRYGPASTTLYVSSGSSMDWAYKNGIPYAFAFELRDT
FT                                GYFGFLLPEMLIKPTCTETMLAVKNITMHLLKKCP -> GK
FT                                FGTNWDPDPKVSAGFTLQNMSPEDSHGRLMFFCM (in
FT                                isoform 2). {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_008808.
FT   VARIANT      45     45       F -> L (in dbSNP:rs10957393).
FT                                /FTId=VAR_024241.
FT   VARIANT     173    173       S -> C (in dbSNP:rs17853192).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_025003.
FT   VARIANT     249    249       N -> S (in dbSNP:rs17343819).
FT                                /FTId=VAR_048597.
FT   VARIANT     267    267       G -> R (in ETL5; affects protein
FT                                secretion presumably by altering protein
FT                                folding or stability; dbSNP:rs61738009).
FT                                {ECO:0000269|PubMed:21922598}.
FT                                /FTId=VAR_066946.
FT   VARIANT     270    270       A -> V (in FEB11; affects protein
FT                                secretion presumably by altering protein
FT                                folding or stability; dbSNP:rs114402678).
FT                                {ECO:0000269|PubMed:21922598}.
FT                                /FTId=VAR_066947.
SQ   SEQUENCE   437 AA;  51008 MW;  9C21780D4B7D0A98 CRC64;
     MKCLGKRRGQ AAAFLPLCWL FLKILQPGHS HLYNNRYAGD KVIRFIPKTE EEAYALKKIS
     YQLKVDLWQP SSISYVSEGT VTDVHIPQNG SRALLAFLQE ANIQYKVLIE DLQKTLEKGS
     SLHTQRNRRS LSGYNYEVYH SLEEIQNWMH HLNKTHSGLI HMFSIGRSYE GRSLFILKLG
     RRSRLKRAVW IDCGIHAREW IGPAFCQWFV KEALLTYKSD PAMRKMLNHL YFYIMPVFNV
     DGYHFSWTND RFWRKTRSRN SRFRCRGVDA NRNWKVKWCD EGASMHPCDD TYCGPFPESE
     PEVKAVANFL RKHRKHIRAY LSFHAYAQML LYPYSYKYAT IPNFRCVESA AYKAVNALQS
     VYGVRYRYGP ASTTLYVSSG SSMDWAYKNG IPYAFAFELR DTGYFGFLLP EMLIKPTCTE
     TMLAVKNITM HLLKKCP
//
